240 related articles for article (PubMed ID: 33193949)
1. [SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF α for Inflammatory Rheumatic Disease].
Malek SA; Bouchti IE
Pan Afr Med J; 2020; 35(Suppl 2):134. PubMed ID: 33193949
[TBL] [Abstract][Full Text] [Related]
2. How to manage rheumatic patients during the coronavirus pandemic.
Parisi S; Ditto MC; Finucci A; Fusaro E
Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
[No Abstract] [Full Text] [Related]
3. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
[TBL] [Abstract][Full Text] [Related]
4. Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.
Duret PM; Sebbag E; Mallick A; Gravier S; Spielmann L; Messer L
Ann Rheum Dis; 2020 Sep; 79(9):1251-1252. PubMed ID: 32354772
[No Abstract] [Full Text] [Related]
5. Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.
Redondo-Sendino Á; González Sánchez IC; de Victoria Fernández B
Med Clin (Barc); 2020 Nov; 155(9):414-415. PubMed ID: 32873395
[No Abstract] [Full Text] [Related]
6. Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
Nuño L; Novella Navarro M; Bonilla G; Franco-Gómez K; Aguado P; Peiteado D; Monjo I; Tornero C; Villalba A; Miranda-Carus ME; De Miguel E; Bogas P; Castilla-Plaza A; Bernad-Pineda M; García-Lorenzo E; Rodríguez-Araya T; Balsa A
Ann Rheum Dis; 2020 Dec; 79(12):1659-1661. PubMed ID: 32606046
[No Abstract] [Full Text] [Related]
7. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
Perricone C; Triggianese P; Bartoloni E; Cafaro G; Bonifacio AF; Bursi R; Perricone R; Gerli R
J Autoimmun; 2020 Jul; 111():102468. PubMed ID: 32317220
[TBL] [Abstract][Full Text] [Related]
8. Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19.
Sun X; Ni Y; Zhang M
Emerg Microbes Infect; 2020 Dec; 9(1):830-832. PubMed ID: 32338155
[TBL] [Abstract][Full Text] [Related]
9. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
Coskun Benlidayi I; Kurtaran B; Tirasci E; Guzel R
Rheumatol Int; 2020 Oct; 40(10):1707-1716. PubMed ID: 32591970
[TBL] [Abstract][Full Text] [Related]
11. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review.
Pereira BB
J Toxicol Environ Health B Crit Rev; 2020 May; 23(4):177-181. PubMed ID: 32281481
[TBL] [Abstract][Full Text] [Related]
12. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
Delaleu J; Deniau B; Battistella M; de Masson A; Bensaid B; Jachiet M; Lazaridou I; Bagot M; Bouaziz JD;
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2777-2779.e1. PubMed ID: 32525093
[No Abstract] [Full Text] [Related]
13. Chloroquine and hydroxychloroquine in covid-19.
Ferner RE; Aronson JK
BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
[No Abstract] [Full Text] [Related]
14. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
Islam M
J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
[No Abstract] [Full Text] [Related]
15. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
[No Abstract] [Full Text] [Related]
16. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.
Funnell SGP; Dowling WE; Muñoz-Fontela C; Gsell PS; Ingber DE; Hamilton GA; Delang L; Rocha-Pereira J; Kaptein S; Dallmeier KH; Neyts J; Rosenke K; de Wit E; Feldmann H; Maisonnasse P; Le Grand R; Frieman MB; Coleman CM
Nat Commun; 2020 Aug; 11(1):4253. PubMed ID: 32848158
[TBL] [Abstract][Full Text] [Related]
17. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
Cairoli E; Espinosa G
Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
[No Abstract] [Full Text] [Related]
19. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
[TBL] [Abstract][Full Text] [Related]
20. A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rueegg CS; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Nat Commun; 2020 Oct; 11(1):5284. PubMed ID: 33082342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
